title: Predictors for visual field progression.
authors.forename: Alon
authors.initials: A
authors.lastname: Harris
authors.forename: Brent
authors.initials: B
authors.lastname: Siesky
authors.forename: Yochai
authors.initials: Y
authors.lastname: Shoshani
authors.forename: Ingrida
authors.initials: I
authors.lastname: Januleviciene
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001783:Blood Flow Velocity; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D009898:Optic Disk / Q000098:blood supply; D012039:Regional Blood Flow; D013449:Sulfonamides / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use; D014786:Vision Disorders / Q000503:physiopathology*; D014794:Visual Fields
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D013843:Thiazines; D013876:Thiophenes; D013999:Timolol; C111827:brinzolamide; C062765:dorzolamide